Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer
Authors:
- 18 August 2006
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 21 (10) , 1596-1603
Abstract
Background and Aim: Recent evidence suggests that the human kallikrein 10 (KLK10) gene is differentially regulated in endocrine‐related tumors and has potential as diagnostic and/or prognostic marker; however, KLK10 expression has never been investigated in gastrointestinal cancers. The aims of this study were to demonstrate expression and single nucleotide polymorphisms of KLK10 in colorectal cancer (CRC) and gastric cancer (GC), and to correlate the relative KLK10 expression level with clinicopathological factors of CRC and GC.Methods: Between March 2004 and January 2005, 63 patients with histologically confirmed CRC and 36 with GC were recruited into the study. Using quantitative real‐time (qRT) RT–PCR and Western blot, KLK10 expression in tumor and non‐tumor colorectal and gastric tissues was determined at the mRNA and protein levels. KLK10 protein was localized by immunohistochemistry. The KLK10 genomic DNA from 16 cases of paired normal/cancerous colorectal tissues was PCR‐amplified and examined for single nucleotide polymorphisms by direct sequencing.Results: KLK10 mRNA expression was detected by qRT in 61 of 63 (96.8%) CRC specimens and in all GC specimens. KLK10 expression was much higher in tumor tissue than in the corresponding normal mucosal tissue at the mRNA and protein levels (P < 0.01). The KLK10 mRNA expression level significantly correlated with lymphatic invasion (P = 0.034) and clinical stage of CRC (P = 0.025). The KLK10 mRNA expression level significantly correlated with the depth of GC invasion (P = 0.018), clinical stage (P = 0.045), patient sex (P = 0.027) and Lauren type of gastric cancer (P = 0.028). No mutations or polymorphisms were detected in exon 1, 2 and 5 of KLK10 gene in CRC. Single nucleotide polymorphisms were identified in codon 50 of exon 3, GCC (alanine) to TCC (serine). The genetic changes of exon 4 were located at codon 106 [GGC (glysine) to GGA (glysine)], codon 112 [ACG (threonine) to ACC (threonine)], codon 141 [CTA (leucine) to CTG (leucine)], and codon 149 [CCG (proline) to CTG (leucine)]. All were identical in tumor and corresponding normal tissue DNA from the same individuals.Conclusion: KLK10 expression is up‐regulated in CRC and GC and higher expression of KLK10 closely correlates with advanced disease stage, which predicts a poorer prognosis; however, further follow‐up study is needed.Keywords
This publication has 25 references indexed in Scilit:
- Intron Retention: A Common Splicing Event within the Human Kallikrein Gene FamilyClinical Chemistry, 2005
- The emerging roles of human tissue kallikreins in cancerNature Reviews Cancer, 2004
- Estimating the Probability of Cancer with Several Tumor Markers in Patients with Colorectal DiseaseOncology, 2004
- Does Serum CA19-9 Play a Practical Role in the Management of Patients With Colorectal Cancer?Diseases of the Colon & Rectum, 2004
- The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical BiomarkersCritical Reviews in Clinical Laboratory Sciences, 2004
- Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiationEuropean Journal of Cancer, 2003
- Plasmin/Plasminogen System in Colorectal CancerWorld Journal of Surgery, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Structural Characterization and Mapping of the Normal Epithelial Cell-Specific 1 GeneBiochemical and Biophysical Research Communications, 1998
- Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970British Journal of Surgery, 1992